BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35931978)

  • 61. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications.
    Valari O; Koliopoulos G; Karakitsos P; Valasoulis G; Founta C; Godevenos D; Dova L; Paschopoulos M; Loufopoulos A; Paraskevaidis E
    Gynecol Oncol; 2011 Sep; 122(3):505-8. PubMed ID: 21665253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical Significance of Detection of Human Papilloma Virus DNA and E6/E7 mRNA for Cervical Cancer Patients.
    Yu T; Wang C
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):155-159. PubMed ID: 35818201
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sensitivity and specificity of HR HPV E6/E7 mRNA test in detecting cervical squamous intraepithelial lesion and cervical cancer.
    Pruski D; Millert-Kalinska S; Lewek A; Kedzia W
    Ginekol Pol; 2019; 90(2):66-71. PubMed ID: 30860271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women.
    Bruno MT; Cassaro N; Vitale SG; Guaita A; Boemi S
    Virol J; 2022 May; 19(1):95. PubMed ID: 35624470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
    J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
    Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age.
    Molden T; Kraus I; Karlsen F; Skomedal H; Hagmar B
    Gynecol Oncol; 2006 Jan; 100(1):95-100. PubMed ID: 16153696
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.
    Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X
    J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.
    Persson M; Elfström KM; Brismar Wendel S; Weiderpass E; Andersson S
    PLoS One; 2014; 9(2):e90023. PubMed ID: 24587193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Diagnostic value of human papillomavirus E6/E7 mRNA for residue and recurrence after cervical conization].
    Zhao H; Shao H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 41(6):606-11. PubMed ID: 27374445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer].
    Wang XH; Qian YM; Miao L; Le Y; Du J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1003-5. PubMed ID: 27453113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.
    Winer RL; Harris TG; Xi LF; Jansen KU; Hughes JP; Feng Q; Welebob C; Ho J; Lee SK; Carter JJ; Galloway DA; Kiviat NB; Koutsky LA
    J Med Virol; 2009 Apr; 81(4):713-21. PubMed ID: 19235870
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.
    Basu P; Banerjee D; Mittal S; Dutta S; Ghosh I; Chowdhury N; Abraham P; Chandna P; Ratnam S
    J Med Virol; 2016 Jul; 88(7):1271-8. PubMed ID: 26693677
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China.
    Zhang J; Yang D; Cui X; Liu G; Cui Z; Wang C; Piao H
    Front Cell Infect Microbiol; 2022; 12():935071. PubMed ID: 36105144
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
    Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
    Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.